XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Non-Insurance Revenues from Contracts with Customers
12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Non-Insurance Revenues from Contracts with Customers Non-Insurance Revenues from Contracts with Customers
Non-Insurance revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs over time as obligations are fulfilled. Revenue is measured as the amount of consideration the Company expects to receive in exchange for providing services.
Deferred Non-Insurance Warranty Revenue
The Company had deferred non-insurance warranty revenue balances of $4.5 billion and $4.0 billion reported in Deferred non-insurance warranty revenue as of December 31, 2021 and 2020. The increase in the deferred revenue balance for the year ended December 31, 2021 was primarily driven by deferrals outpacing revenue recognized in the period due to growth in the business. For the year ended December 31, 2021, the Company recognized $1.2 billion of revenues that were included in the deferred revenue balance as of January 1, 2021. For the year ended December 31, 2020, the Company recognized $1.1 billion of revenues that were included in the deferred revenue balance as of January 1, 2020. For the years ended December 31, 2021 and 2020, Non-insurance warranty revenue recognized from performance obligations related to prior periods due to a change in estimate was not material. The Company expects to recognize approximately $1.3 billion of the deferred revenue in 2022, $1.0 billion in 2023, $0.8 billion in 2024 and $1.3 billion thereafter.
Cost to Obtain and Fulfill Non-Insurance Warranty Contracts with Customers
For the years ended December 31, 2021 and 2020, capitalized commission costs were $3.5 billion and $3.1 billion and capitalized administrator service costs were $47 million and $37 million. For the years ended December 31, 2021 and 2020, the amount of amortization of capitalized costs was $1.1 billion and $0.9 billion and there were no impairment losses related to the costs capitalized. There were no adjustments to deferred costs recorded for the years ended December 31, 2021 and 2020.